India · Delayed Price · Currency is INR AstraZeneca Pharma India Statistics
Total Valuation
NSE:ASTRAZEN has a market cap or net worth of INR 210.17 billion. The enterprise value is 206.79 billion.
| Market Cap | 210.17B |
| Enterprise Value | 206.79B |
Important Dates
The last earnings date was Tuesday, May 26, 2026.
| Earnings Date | May 26, 2026 |
| Ex-Dividend Date | Jul 18, 2025 |
Share Statistics
| Current Share Class | 25.00M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 6.18% |
| Owned by Institutions (%) | 8.30% |
| Float | 4.60M |
Valuation Ratios
The trailing PE ratio is 112.08.
| PE Ratio | 112.08 |
| Forward PE | n/a |
| PS Ratio | 9.24 |
| PB Ratio | 24.08 |
| P/TBV Ratio | 24.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 110.27 |
| EV / Sales | 9.09 |
| EV / EBITDA | 78.92 |
| EV / EBIT | 88.58 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.77 |
| Quick Ratio | 0.67 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.42 |
| Debt / FCF | -6.63 |
| Interest Coverage | 51.99 |
Financial Efficiency
Return on equity (ROE) is 22.82% and return on invested capital (ROIC) is 35.84%.
| Return on Equity (ROE) | 22.82% |
| Return on Assets (ROA) | 8.32% |
| Return on Invested Capital (ROIC) | 35.84% |
| Return on Capital Employed (ROCE) | 23.18% |
| Weighted Average Cost of Capital (WACC) | 5.63% |
| Revenue Per Employee | 37.93M |
| Profits Per Employee | 3.13M |
| Employee Count | 600 |
| Asset Turnover | 1.30 |
| Inventory Turnover | 1.75 |
Taxes
In the past 12 months, NSE:ASTRAZEN has paid 646.80 million in taxes.
| Income Tax | 646.80M |
| Effective Tax Rate | 25.65% |
Stock Price Statistics
The stock price has decreased by -13.36% in the last 52 weeks. The beta is 0.25, so NSE:ASTRAZEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -13.36% |
| 50-Day Moving Average | 8,469.12 |
| 200-Day Moving Average | 8,757.03 |
| Relative Strength Index (RSI) | 48.17 |
| Average Volume (20 Days) | 11,546 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ASTRAZEN had revenue of INR 22.76 billion and earned 1.88 billion in profits. Earnings per share was 75.01.
| Revenue | 22.76B |
| Gross Profit | 8.95B |
| Operating Income | 2.33B |
| Pretax Income | 2.52B |
| Net Income | 1.88B |
| EBITDA | 2.62B |
| EBIT | 2.33B |
| Earnings Per Share (EPS) | 75.01 |
Balance Sheet
The company has 4.49 billion in cash and 1.11 billion in debt, with a net cash position of 3.38 billion.
| Cash & Cash Equivalents | 4.49B |
| Total Debt | 1.11B |
| Net Cash | 3.38B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 8.73B |
| Book Value Per Share | 349.08 |
| Working Capital | 7.58B |
Cash Flow
In the last 12 months, operating cash flow was -151.40 million and capital expenditures -15.60 million, giving a free cash flow of -167.00 million.
| Operating Cash Flow | -151.40M |
| Capital Expenditures | -15.60M |
| Depreciation & Amortization | 285.80M |
| Net Borrowing | -74.80M |
| Free Cash Flow | -167.00M |
| FCF Per Share | n/a |
Margins
Gross margin is 39.33%, with operating and profit margins of 10.26% and 8.24%.
| Gross Margin | 39.33% |
| Operating Margin | 10.26% |
| Pretax Margin | 11.08% |
| Profit Margin | 8.24% |
| EBITDA Margin | 11.51% |
| EBIT Margin | 10.26% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 32.00, which amounts to a dividend yield of 0.38%.
| Dividend Per Share | 32.00 |
| Dividend Yield | 0.38% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 42.66% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.38% |
| Earnings Yield | 0.89% |
| FCF Yield | -0.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |